Table 3.
Study | n | Follow-up, median/months | Survival |
---|---|---|---|
Jaques et al. [2], 1995 | 14 | 60 | Median OS 30 months, 5-year OS was 0%* |
Harrison et al. [24], 1997 | 27 | 60 | Median OS 31 months, 5-year OS was 4%* |
Elias et al. [25], 1998 | 13 | Unknown | 5-Year OS 18%* |
Chen et al. [26], 1998 | 11 | 53 | Median OS 39 months* |
Lang et al. [27], 2000 | 26 | Unknown | Median OS after R0 resection: 32 months, 5-year OS 13% |
DeMatteo et al. [8], 2001 | 22 | 25 | Median OS 30 months |
Pawlik et al. [16], 2006 | 66 | 35.8 | 1-Year OS 91.2%, 5-year OS 27%** |
Adam et al. [23], 2006 | 125 | Mean FU: 31 months | Median OS 32 months, 5-year OS 31% |
Lendoire et al. [28], 2007 | 23 | 28 | 5-Year OS 0% |
Rehders et al. [29], 2009 | 27 | 84 | Median OS 44 months, 5-year OS 49%^ |
Chua et al. [22], 2011 | 15 | 122 | Median OS 103 months, 5-year OS: 51%, 10-year OS: 37%^ |
Marudanayagam et al. [11], 2011 | 36 | 24 | Median OS 24 months, 5-year OS 32%^ |
Zacherl et al. [30], 2011 | 15 | Unknown | Median OS 34 months, 5-year OS 27%^ |
Groeschl et al. [9], 2012 | 98 | 32 | Median OS 72 months, 1-year OS: 82%, 5-year OS 32%*** |
Brudvik et al. [10], 2015 | 50 | 32 | Median OS 45 months, 5-year OS 45%, 10-year OS 23% |
Study population included before 1996.
Study population included 36 Gastrointestinal stromal tumours, 13 patients were treated with RFA only.
Excluded all R1- and R2-resections.
Study population included Sarcomas and Gastrointestinal stromal tumours.